Gene: CCDC167

154467
C6orf129|HSPC265
coiled-coil domain containing 167
protein-coding
6p21.2
Ensembl:ENSG00000198937 Vega:OTTHUMG00000014625 UniprotKB:Q9P0B6
NC_000006.12
SNP Mapped
1   ANCO-SNPs
AD
0   
6.786e-2 (AD)  7.544e-1 (ND)   (Frontal_Cortex)
3.039e-2 (AD)  7.166e-1 (ND)

ANCO-SNPs

SNP ID Position Alleles Trait Variation Type
rs2646937chr6:37501761 (GRCh38.p7)C>Talcohol dependenceSNV(Single Nucleotide Variation)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
MRPL520.805
ZNHIT10.794
MRPL430.79
BANF10.789
LSM70.787
DTYMK0.786
PHPT10.781
POLD20.779
NOP100.777
SEC61B0.776

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
OR4F5-0.594
OR4F29-0.553
ZIM2-0.246
TBX4-0.237
PRTG-0.235
P2RY14-0.231
OR13C3-0.227
OR52H1-0.227
ILDR1-0.226
TTN-0.224

Drugs/Compounds

    There is no DrugBank record for this gene !

ID Drug Name Action PubMed
C006780bisphenol Abisphenol A affects the expression of CCDC167 mRNA25181051
C006780bisphenol A[bisphenol A co-treated with Testosterone] results in increased expression of CCDC167 mRNA26496021
C000611646bisphenol F[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CCDC167 mRNA28628672
D019327Copper SulfateCopper Sulfate results in decreased expression of CCDC167 mRNA19549813
D003375CoumestrolCoumestrol results in increased expression of CCDC167 mRNA19167446
D016572CyclosporineCyclosporine results in increased expression of CCDC167 mRNA20106945|2556210
C014347decitabinedecitabine affects the expression of CCDC167 mRNA23300844
D003907Dexamethasone[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CCDC167 mRNA28628672
D002945CisplatinCisplatin affects the expression of CCDC167 mRNA23300844
D002945Cisplatin[Cisplatin co-treated with jinfukang] results in increased expression of CCDC167 mRNA27392435
D002945CisplatinCisplatin results in increased expression of CCDC167 mRNA27594783
C045651epigallocatechin gallateepigallocatechin gallate results in decreased expression of CCDC167 mRNA22079256
C045651epigallocatechin gallate[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CCDC167 mRNA22079256
D005897GlafenineGlafenine results in increased expression of CCDC167 mRNA24136188
C492448ICG 001ICG 001 results in increased expression of CCDC167 mRNA26191083
D007213Indomethacin[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CCDC167 mRNA28628672
D0150561-Methyl-3-isobutylxanthine[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CCDC167 mRNA28628672
C544151jinfukang[Cisplatin co-treated with jinfukang] results in increased expression of CCDC167 mRNA27392435
C544151jinfukangjinfukang results in increased expression of CCDC167 mRNA27392435
C561695(+)-JQ1 compound(+)-JQ1 compound results in decreased expression of CCDC167 mRNA23086925
C410337K 7174K 7174 results in decreased expression of CCDC167 mRNA24086573
D037742Nanotubes, Carbon"Nanotubes, Carbon analog results in increased expression of CCDC167 mRNA"25554681|2562005
D037742Nanotubes, Carbon"Nanotubes, Carbon results in decreased expression of CCDC167 mRNA"25554681
D009532NickelNickel results in increased expression of CCDC167 mRNA25583101
C029938nickel sulfatenickel sulfate results in increased expression of CCDC167 mRNA22714537
D009538NicotineNicotine results in increased expression of CCDC167 mRNA23825647
C027373potassium chromate(VI)[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CCDC167 mRNA22079256
C027373potassium chromate(VI)potassium chromate(VI) results in decreased expression of CCDC167 mRNA22079256
D018038Sodium SeleniteSodium Selenite results in increased expression of CCDC167 mRNA18175754
D013739Testosterone[bisphenol A co-treated with Testosterone] results in increased expression of CCDC167 mRNA26496021
C009495titanium dioxidetitanium dioxide results in increased expression of CCDC167 mRNA23557971|2776080
C016805tris(1,3-dichloro-2-propyl)phosphate"tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of CCDC167 mRNA"26179874
D014415TunicamycinTunicamycin results in decreased expression of CCDC167 mRNA22378314
D014635Valproic AcidValproic Acid affects the expression of CCDC167 mRNA25979313
D014635Valproic AcidValproic Acid results in increased expression of CCDC167 mRNA23179753|2800136
C029297vinylidene chloridevinylidene chloride results in increased expression of CCDC167 mRNA26682919

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO ID GO Term Qualifier Evidence PubMed
GO ID GO Term Qualifier Evidence PubMed
GO:0016021integral component of membrane-IEA-  
KEGG ID KEGG Term
Reactome ID Reactome Term Evidence

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal